Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  251.99
-2.01 (-0.79%)
AAPL  270.42
+1.37 (0.51%)
AMD  255.16
-4.49 (-1.73%)
BAC  53.67
+0.11 (0.21%)
GOOG  279.39
-4.73 (-1.66%)
META  632.19
-5.52 (-0.87%)
MSFT  513.10
-3.93 (-0.76%)
NVDA  201.85
-5.03 (-2.43%)
ORCL  252.79
-5.06 (-1.96%)
TSLA  452.90
-15.47 (-3.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.